Biofilm Formation and Aspartyl Proteinase Activity and Their Association with Azole Resistance Among Candida albicans Causing Vulvovaginal Candidiasis, Egypt

References

• Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961–1971. doi:10.1016/S0140-6736(07)60917-9
   PubMed Web of Science ®Google Scholar
• Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016;42(6):905–927. doi:10.3109/1040841X.2015.1091805
   PubMed Web of Science ®Google Scholar
• Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339–e347. doi:10.1016/S1473-3099(18)30103-8
   PubMed Web of Science ®Google Scholar
• Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340–345. doi:10.1097/LGT.0b013e318273e8cf
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Kargar ML, Mohammadi SR, et al. A high rate of recurrent vulvovaginal candidiasis and therapeutic failure of azole derivatives among Iranian women. Front Microbiol. 2021;28(12):655069. doi:10.3389/fmicb.2021.655069
   Google Scholar
• Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19(1):5. doi:10.1186/s12941-020-0347-4
   PubMed Web of Science ®Google Scholar
• ElFeky DS, Gohar NM, El-Seidi EA, Ezzat MM, AboElew SH. Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis. Alexandria J Med. 2016;52(3):269–277. doi:10.1016/j.ajme.2015.10.001
   Web of Science ®Google Scholar
• Rezaei-Matehkolaei A, Shafiei S, Zarei-Mahmoudabadi A. Isolation, molecular identification, and antifungal susceptibility profiles of vaginal isolates of Candida species. Iran J Microbiol. 2016;8(6):410–417.
   PubMedGoogle Scholar
• Anh DN, Hung DN, Tien TV, et al. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam. BMC Infect Dis. 2021;21(1):523. doi:10.1186/s12879-021-06192-7
   PubMed Web of Science ®Google Scholar
• Kennedy MA, Sobel JD. Vulvovaginal candidiasis caused by non-albicans Candida species: new insights. Curr Infect Dis Rep. 2010;12(6):465–470. doi:10.1007/s11908-010-0137-9
   PubMedGoogle Scholar
• Bitew A, Abebaw Y. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. BMC Womens Health. 2018;18(1):94. doi:10.1186/s12905-018-0607-z
   PubMedGoogle Scholar
• Makanjuola O, Bongomin F, Fayemiwo SA. An update on the roles of non-albicans Candida species in vulvovaginitis. J Fungi. 2018;4(4):121. doi:10.3390/jof4040121
   Web of Science ®Google Scholar
• Ciurea CN, Kosovski IB, Mare AD, Toma F, Pintea-Simon IA, Man A. Candida and candidiasis-opportunism versus pathogenicity: a review of the virulence traits. Microorganisms. 2020;8(6):857. doi:10.3390/microorganisms8060857
   PubMed Web of Science ®Google Scholar
• Sandai D, Tabana YM, Ouweini AE, Ayodeji IO. Resistance of Candida albicans biofilms to drugs and the host immune system. Jundishapur J Microbiol. 2016;9(11):e37385. doi:10.5812/jjm.37385
   PubMed Web of Science ®Google Scholar
• Gulati M, Nobile CJ. Candida albicans biofilms: development, regulation, and molecular mechanisms. Microbes Infect. 2016;18(5):310–321. doi:10.1016/j.micinf.2016.01.002
   PubMed Web of Science ®Google Scholar
• Cota E, Hoyer LL. The Candida albicans agglutinin-like sequence family of adhesins: functional insights gained from structural analysis. Future Microbiol. 2015;10(10):1635. doi:10.2217/fmb.15.79
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006;5(10):1604–1610. doi:10.1128/EC.00194-06
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Schneider HA, Nett JE, et al. Complementary adhesin function in C. albicans biofilm formation. Curr Biol. 2008;18(14):1017–1024. doi:10.1016/j.cub.2008.06.034
   PubMed Web of Science ®Google Scholar
• Staib F. Proteolysis and pathogenicity of Candida albicans strains. Myopathic Mycol Appl. 1969;37(4):345–348. doi:10.1007/BF02129881
   PubMed Web of Science ®Google Scholar
• Kulshrestha A, Gupta P. Secreted aspartyl proteases family: a perspective review on the regulation of fungal pathogenesis. Future Microbiol. 2023;18:295–309. doi:10.2217/fmb-2022-0143
   PubMed Web of Science ®Google Scholar
• Naglik J, Albrecht A, Bader O, Hube B. Candida albicans proteinases and host/pathogen interactions. Cell Microbiol. 2004;6(10):915. doi:10.1111/j.1462-5822.2004.00439.x
   PubMed Web of Science ®Google Scholar
• De Bernardis F, Cassone A, Sturtevant J, Calderone R. Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun. 1995;63(5):1887–1892. doi:10.1128/iai.63.5.1887-1892.1995
   PubMed Web of Science ®Google Scholar
• De Bernardis F, Boccanera M, Adriani D, Girolamo A, Cassone A. Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis. Infection Immunol. 2002;70:2725–2729. doi:10.1128/IAI.70.5.2725-2729.2002
   PubMed Web of Science ®Google Scholar
• Burden AM, Hausammann L, Ceschi A, Kupferschmidt H, Weiler S. Observational cross-sectional case study of toxicities of antifungal drugs. J Glob Antimicrob Resist. 2022;29:520–526. doi:10.1016/j.jgar.2021.11.010
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Sae-Tia S, Fries BC. Candidiasis and mechanisms of antifungal resistance. Antibiotics. 2020;9(6):312. doi:10.3390/antibiotics9060312
   Google Scholar
• Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;12:2173.
   Google Scholar
• Salvi M. Prevalence of vulvovaginal candidiasis in females in the reproductive age group. Int J Reprod Contracept Obstet Gynecol. 2019;8(2):647–651. doi:10.18203/2320-1770.ijrcog20190299
   Google Scholar
• Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297–301. doi:10.1128/jcm.29.2.297-301.1991
   PubMed Web of Science ®Google Scholar
• Coleman DC, Bennett DE, Sullivan DJ, et al. Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Rev Microbiol. 1993;19(2):61–82. doi:10.3109/10408419309113523
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline 2nd Ed, M44-A2. Wayne: Clinical and Laboratory Standards Institute; 2009.
   Google Scholar
• Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol. 2003;41(7):2961–2967. doi:10.1128/JCM.41.7.2961-2967.2003
   PubMed Web of Science ®Google Scholar
• Stepanović S, Vuković D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007;115(8):891–899. doi:10.1111/j.1600-0463.2007.apm_630.x
   PubMed Web of Science ®Google Scholar
• Cassone A, De Bernardis F, Mondello F, Ceddia T, Agatensi L. Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J Infect Dis. 1987;156(5):777–783. doi:10.1093/infdis/156.5.777
   PubMed Web of Science ®Google Scholar
• Naglik JR, Rodgers CA, Shirlaw PJ, et al. Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections. J Infect Dis. 2003;188(3):469–479. doi:10.1086/376536
   PubMed Web of Science ®Google Scholar
• Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, Hoyer LL. RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology. 2004;150(Pt 2):267–275. doi:10.1099/mic.0.26699-0
   PubMedGoogle Scholar
• Naglik JR, Fostira F, Ruprai J, Staab JF, Challacombe SJ, Sundstrom P. Candida albicans HWP1 gene expression and host antibody responses in colonization and disease. J Med Microbiol. 2006;55(Pt 10):1323–1327. doi:10.1099/jmm.0.46737-0
   PubMed Web of Science ®Google Scholar
• Sobel JD, Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Expert Opin Pharmacother. 2018;19(9):971–977. doi:10.1080/14656566.2018.1476490
   PubMed Web of Science ®Google Scholar
• El-Houssaini HH, Elnabawy OM, Nasser HA, Elkhatib WF. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens. Microb Pathog. 2019;128:13–19. doi:10.1016/j.micpath.2018.12.028
   PubMed Web of Science ®Google Scholar
• Monroy-Pérez E, Rodríguez-Bedolla RM, Garzón J, Vaca-Paniagua F, Arturo-Rojas Jiménez E, Paniagua-Contreras GL. Marked virulence and azole resistance in Candida albicans isolated from patients with periodontal disease. Microb Pathog. 2020;148:104436. doi:10.1016/j.micpath.2020.104436
   PubMed Web of Science ®Google Scholar
• Bohner F, Papp C, Gácser A. The effect of antifungal resistance development on the virulence of Candida species. FEMS Yeast Res. 2022;22(1):foac019. doi:10.1093/femsyr/foac019
   PubMed Web of Science ®Google Scholar
• Popp C, Ramírez-Zavala B, Schwanfelder S, Krüger I, Morschhäuser J, Berman J. Evolution of fluconazole-resistant Candida albicans strains by drug-induced mating competence and parasexual recombination. mBio. 2019;10(1):e02740–18. doi:10.1128/mBio.02740-18
   PubMed Web of Science ®Google Scholar
• Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M. The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis. 2012;73(1):45–48. doi:10.1016/j.diagmicrobio.2012.02.001
   PubMed Web of Science ®Google Scholar
• Tan TY, Hsu LY, Alejandria MM, et al. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region. Med Mycol. 2016;54(5):471–477. doi:10.1093/mmy/myv114
   PubMed Web of Science ®Google Scholar
• Ali A, Azab M, Abdelrahman A. Distribution of secreted aspartyl protease (SAP) virulence genes and antifungal resistance genes at vulvovaginal candidiasis isolates. GSC Biol Pharm Sci. 2018;5(3):86–94. doi:10.30574/gscbps.2018.5.3.0149
   Google Scholar
• Marak MB, Dhanashree B. Antifungal susceptibility and biofilm production of Candida spp. isolated from clinical samples. Int J Microbiol. 2018;10:7495218.
   Google Scholar
• Yenisehirli G, Bulut N, Yenisehirli A, Bulut Y. In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey. Jundishapur J Microbiol. 2015;8(9):e28057. doi:10.5812/jjm.28057
   PubMed Web of Science ®Google Scholar
• Erum R, Samad F, Khan A, Kazmi SU. A comparative study on production of extracellular hydrolytic enzymes of Candida species isolated from patients with surgical site infection and from healthy individuals and their co-relation with antifungal drug resistance. BMC Microbiol. 2020;20(1):368. doi:10.1186/s12866-020-02045-6
   PubMed Web of Science ®Google Scholar
• Shrief R, Zaki ME, El-Sehsah EM, Ghaleb S, Mofreh M. Study of antifungal susceptibility, virulence genes and biofilm formation in Candida albicans. Open Microbiol J. 2019;13:241–248. doi:10.2174/1874285801913010241
   Google Scholar
• Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol. 1993;36(1):153–165. doi:10.1097/00003081-199303000-00021
   PubMed Web of Science ®Google Scholar
• Phillips AJ. Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories. Am J Obstet Gynecol. 2005;192(6):2009–12; discussion 2012–3. doi:10.1016/j.ajog.2005.03.034
   PubMed Web of Science ®Google Scholar
• Mendling W, Brasch J, Cornely OA, et al. Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis). Mycoses. 2015;58(Suppl 1):1–15. doi:10.1111/myc.12292
   PubMedGoogle Scholar
• Wu X, Zhang S, Li H, et al. Biofilm formation of Candida albicans facilitates fungal infiltration and persister cell formation in vaginal candidiasis. Front Microbiol. 2020;11:1117. doi:10.3389/fmicb.2020.01117
   PubMed Web of Science ®Google Scholar
• Kadry AA, El-Ganiny AM, El-Baz AM. Relationship between Sap prevalence and biofilm formation among resistant clinical isolates of Candida albicans. Afr Health Sci. 2018;18(4):1166–1174. doi:10.4314/ahs.v18i4.37
   PubMed Web of Science ®Google Scholar
• Hamady A, Marei Y. Detection of als1 and hwp1 genes involved in biofilm formation in Candida albicans isolated from catheter-associated candiduria. Microbes Infect Dis. 2021;2:558–566.
   Google Scholar
• Sadanandan B, Vaniyamparambath V, Lokesh KN, et al. Candida albicans biofilm formation and growth optimization for functional studies using response surface methodology. J Appl Microbiol. 2022;132(4):3277–3292. doi:10.1111/jam.15402
   PubMed Web of Science ®Google Scholar
• Estivill D, Arias A, Torres-Lana A, Carrillo-Muñoz AJ, Arévalo MP. Biofilm formations by five species of Candida on three clinical materials. J Microbiol Methods. 2011;86(2):238–242. doi:10.1016/j.mimet.2011.05.019
   PubMed Web of Science ®Google Scholar
• Silva S, Rodrigues CF, Araújo D, Rodrigues ME, Henriques M. Candida Species biofilms’ antifungal resistance. J Fungi. 2017;3(1):8. doi:10.3390/jof3010008
   Web of Science ®Google Scholar
• Chandra J, Mukherjee PK, Ghannoum M, Parsek M, Whiteley M, Mukherjee P. Candida biofilms: development, architecture, and resistance. Microbiol Spectr. 2015;3(4):10. doi:10.1128/microbiolspec.MB-0020-2015
   Google Scholar
• Mohammadi F, Ghasemi Z, Familsatarian B, et al. Relationship between antifungal susceptibility profile and virulence factors in Candida albicans isolated from nail specimens. Rev Soc Bras Med Trop. 2020;7:53.
   Google Scholar
• Tulasidas S, Rao P, Bhat S, Manipura R. A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections. Infect Drug Resist. 2018;11:2443–2448. doi:10.2147/IDR.S179462
   PubMed Web of Science ®Google Scholar
• Song NN, Qian GY, Zheng HL, et al. Biofilm alterations on the stepwise acquisition of fluconazole-resistant Candida albicans isolates. Int J Dermatol Venereol. 2022;5(3):132–139. doi:10.1097/JD9.0000000000000223
   PubMedGoogle Scholar
• Czechowicz P, Nowicka J, Gościniak G. Virulence factors of Candida spp. and host immune response important in the pathogenesis of vulvovaginal candidiasis. Int J Mol Sci. 2022;23(11):5895. doi:10.3390/ijms23115895
   PubMed Web of Science ®Google Scholar
• Araújo Paulo de Medeiros M, de Melo AP V, de Sousa AM M, Silva-Rocha WP, Pipolo Milan E, Maranhão Chaves G. Characterization of virulence factors of vaginal and anal isolates of Candida albicans sequentially obtained from patients with vulvovaginal candidiasis in north-east Brazil. J Mycol Med. 2017;27(4):567–572. doi:10.1016/j.mycmed.2017.06.002
   PubMed Web of Science ®Google Scholar
• Ramos Lde S, Barbedo LS, Braga-Silva LA, Dos Santos AL, Pinto MR, Sgarbi DB. Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis. Rev Iberoam Micol. 2015;32(2):122–125. doi:10.1016/j.riam.2014.01.003
   PubMed Web of Science ®Google Scholar
• de Paula Menezes R, de Melo Riceto ÉB, Borges AS, de Brito Röder DV, Dos Santos Pedroso R. Evaluation of virulence factors of Candida albicans isolated from HIV-positive individuals using HAART. Arch Oral Biol. 2016;66:61–65. doi:10.1016/j.archoralbio.2016.02.004
   PubMed Web of Science ®Google Scholar
• Sardi JC, Duque C, Höfling JF, Gonçalves RB. Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol. 2012;50(5):467–475. doi:10.3109/13693786.2011.633233
   PubMed Web of Science ®Google Scholar
• Majumdar T, Mullick JB, Bir R, Roy J, Sil SK. Determination of virulence factors and biofilm formation among isolates of vulvovaginal candidiasis. J Med Sci. 2016;36(2):53–58. doi:10.4103/1011-4564.181521
   Google Scholar
• Lima JS, Braga KRGS, Vieira CA, et al. Genotypic analysis of secreted aspartyl proteinases in vaginal Candida albicans isolates. J Bras Patol Med Lab. 2018;54(1):28–33.
   Google Scholar
• Lian CH, Liu WD. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Mycoses. 2007;50(5):383–390. doi:10.1111/j.1439-0507.2007.01384.x
   PubMed Web of Science ®Google Scholar
• Naglik JR, Moyes D, Makwana J, et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology. 2008;154(Pt 11):3266–3280. doi:10.1099/mic.0.2008/022293-0
   PubMedGoogle Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119–128. doi:10.4161/viru.22913
   PubMed Web of Science ®Google Scholar
• Dostál J, Hamal P, Pavlícková L, et al. Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. J Clin Microbiol. 2003;41(2):712–716. doi:10.1128/JCM.41.2.712-716.2003
   PubMed Web of Science ®Google Scholar
• Bentubo HD, Gompertz OF. Effects of temperature and incubation time on the in vitro expression of proteases, phospholipases, lipases and DNases by different species of Trichosporon. Springerplus. 2014;3:377. doi:10.1186/2193-1801-3-377
   PubMedGoogle Scholar